Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG

Ra Capital Management, L.P. bought 67,669 Hemab Therapeutics Holdings, Inc. shares (Form 4)

Traded Jun 15 to Jun 16, 2026 · Filed Jun 17, 2026

From Jun 15 to Jun 16, 2026, Ra Capital Management, L.P. (10% owner) bought 67,669 Hemab Therapeutics Holdings, Inc. shares at an average US$24.97 for US$1.69M, leaving 6,444,637 shares. Filed Jun 17, 2026 (Form 4).

Bought
67,669 shares
Price
US$24.97 average (US$24.89 to US$24.98)
Value
US$1.69M
Holding after
6,444,637 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockBuy6,146US$24.896,383,114Indirect
Jun 16, 2026Common StockBuy61,523US$24.986,444,637Indirect

Source

View original at SEC

Related